Pharmaceutical companies to promote the production and sales of Chinese herbal pieces
Release time:
2022-12-13
walked into the traditional Chinese medicine decoction pieces workshop of Jinhua pharmaceutical company. the air was full of strong flavor of traditional Chinese medicine. the cooking machine "poop-poop " in the cooking room was steaming. the staff in charge of the care came to check the production situation from time to time. In the washing room, the machinery and equipment have just been cleaned, waiting for the next batch of medicinal materials "patronage " , several employees cooperate with tacit understanding, skillfully put Chinese herbal medicine into packaging bags, weighing, sealing, packing and storing in the warehouse, waiting to be shipped to the market ...... This is the production of Chinese herbal medicine workshop normal.
In the past two years, the sales volume and production orders of Chinese herbal pieces of pharmaceutical companies have increased significantly. In order to ensure that all orders of Chinese herbal pieces can be completed with good quality and quantity, the front-line production workers are working at full capacity and working overtime to put into production. Due to space constraints, the Chinese herbal medicine workshop arranges up to three different varieties of Chinese medicine production at a time, interspersed with processing procedures such as cleaning, slicing, drying, sterilization, packaging and storage. The weekly business department of the workshop receives orders for production and scheduling. The production volume of 16-20 tons of Chinese herbal pieces should be completed in one month, reaching 90 tons in one month at most. The production workshop is busy with production. When the business and storage personnel are tight, the pharmaceutical company also organizes logistics personnel to help ensure the on-time delivery of orders.
"The implementation of the new policy of no more than 25% of Chinese herbal pieces has not only reduced the medical expenses of patients, effectively guided the masses to choose more Chinese medicine services, but also promoted the concept of high quality and good price of Chinese herbal pieces. Wu Weisheng, general manager of " Pharmaceutical Company, said that on the 28th of June 1# this year, the "Implementation Opinions of Zhejiang Medical Security Bureau on Supporting the Inheritance and Innovation of Traditional Chinese Medicine" was formally implemented. Zhejiang Province required public medical institutions to strictly implement the bonus policy of increasing 25% sales according to the actual purchase price. The prices of Chinese herbal pieces in many places have dropped significantly, medical institutions pay more attention to the quality of drugs when purchasing Chinese herbal pieces. With the help of this policy change, pharmaceutical companies further optimize the suppliers of raw medicinal materials and purchase raw materials on the premise of high quality and good price. Every process in the production process is very strict. In addition to the on-site follow-up by the quality inspection personnel, each batch of traditional Chinese medicine produced is sent to the quality inspection center for inspection to ensure the quality of each batch of medicinal materials and give full play to the curative effect of medicinal materials. so that people can use conscience medicine, rest assured medicine and fine medicine anytime and anywhere. The high quality of products naturally drives the increase of sales volume. The output of Chinese herbal medicine workshop has also increased significantly compared with the same period last year, and the market development has also reached a new high. This year, the pharmaceutical company successfully broke through from
14suppliers of traditional Chinese medicine and became one of 2 suppliers of Jinhua Hospital of Traditional Chinese Medicine. The sales volume directly doubled from the original small proportion. 4# Starting in 39, the bid for the distribution right of Chinese herbal pieces of medical institutions in Pan 'an County was won. , distribution bidding for township hospitals in Wucheng District, the pharmaceutical company ranked first in the distribution enterprise in terms of qualification, service and sample quality. The sales volume of Chinese herbal pieces in a hospital in Yongkang has also doubled this year. The relevant person in charge of the Chinese medicine department of the pharmaceutical company said that the increase in production capacity and sales, with sales, not only ensures product quality, but also reduces procurement costs to a certain extent, forming a healthy development of production and sales. Wu Weisheng said that at present, the traditional Chinese medicine decoction pieces business of pharmaceutical companies includes production and trade, with both self-operated varieties and OEM products. Next, pharmaceutical companies will also give full play to their advantages, adjust the industrial structure, and make every effort to promote the production and sales of Chinese herbal pieces according to the actual production of enterprises.
(ReporterNi Yingzhen)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page